Conjugate vaccine against group C meningococcus: Filed for U.K. approval to begin a Phase I trial of safety and immunogenicity in healthy adults

North American Vaccine Inc. (NVX), Beltsville, Md. Product: Conjugate vaccine against group C meningococcus Indication: Bacterial meningitis Status: Filed for U.K. approval to begin a Phase I trial of...